AMGN Matthew C Busch sells $376K worth of shares
Feb 21, 2026, 5:32 AM
0.00%
What does AMGN do
Amgen, headquartered in Thousand Oaks, California, is a biotechnology company employing 26,700 staff, focusing on developing human therapeutics for high unmet medical needs. Its product portfolio includes Aranesp, ENBREL, and Prolia, among others.
Matthew C Busch sold 1,000 shares of AMGN on 19 February at $375.79 per share, worth a total of $376K. They now own 3,423 AMGN shares, or a 23% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.